Literature DB >> 20381067

High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome.

Li-Ping Zhang1, Bin Hui, Bing-Ren Gao.   

Abstract

Familial appearance of Wolff-Parkinson-White (WPW) syndrome is rare and displays an autosomal dominant inheritance. Here we report a Chinese kindred of WPW syndrome whose unique clinical features consist of a high risk of sudden cardiac death due to atrial fibrillation, causing a rapid antegrade conduct over the accessory pathway. The mutation in the PRKAG2 gene was identified as responsible for the familial form of WPW syndrome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381067     DOI: 10.1016/j.jelectrocard.2010.02.009

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  8 in total

Review 1.  Clinical Spectrum of PRKAG2 Syndrome.

Authors:  Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

Review 2.  Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9.

Authors:  Ronen Ben Jehuda; Yuval Shemer; Ofer Binah
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

3.  Sudden cardiac death due to the Wolff-Parkinson-White syndrome: A case report with genetic analysis.

Authors:  Mingjie Qiu; Bin Lv; Wei Lin; Jing Ma; Hongmei Dong
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

4.  Novel PRKAG2 variant presenting as liver cirrhosis: report of a family with 2 cases and review of literature.

Authors:  Zahra Beyzaei; Fatih Ezgu; Bita Geramizadeh; Alireza Alborzi; Alireza Shojazadeh
Journal:  BMC Med Genomics       Date:  2021-01-28       Impact factor: 3.063

Review 5.  Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes.

Authors:  Emanuele Monda; Marta Rubino; Michele Lioncino; Francesco Di Fraia; Roberta Pacileo; Federica Verrillo; Annapaola Cirillo; Martina Caiazza; Adelaide Fusco; Augusto Esposito; Fabio Fimiani; Giuseppe Palmiero; Giuseppe Pacileo; Paolo Calabrò; Maria Giovanna Russo; Giuseppe Limongelli
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.569

6.  Long-Term Cardiac Complications of PRKAG2 Syndrome.

Authors:  Luiz Pereira de Magalhães; Eduardo Faria Soares de Magalhães; Jussara de Oliveira Pinheiro; Alex Teixeira Guabiru; Francisco José Farias Borges Dos Reis; Roque Aras
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

7.  Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.

Authors:  Pauli Pöyhönen; Anita Hiippala; Laura Ollila; Touko Kaasalainen; Helena Hänninen; Tiina Heliö; Jonna Tallila; Catalina Vasilescu; Sari Kivistö; Tiina Ojala; Miia Holmström
Journal:  J Cardiovasc Magn Reson       Date:  2015-10-24       Impact factor: 5.364

8.  Phenotypic expression and clinical outcomes in a South Asian PRKAG2 cardiomyopathy cohort.

Authors:  Hisham Ahamed; Aniketh Vijay Balegadde; Shilpa Menon; Ramesh Menon; Aishwarya Ramachandran; Navin Mathew; K U Natarajan; Indu Ramachandran Nair; Rajesh Kannan; Meghna Shankar; Oommen K Mathew; Thong T Nguyen; Ravi Gupta; Eric W Stawiski; V L Ramprasad; Somasekar Seshagiri; Sameer Phalke
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.